Yahoo
Shenzhen - Delayed Quote CNY

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)

25.28 +0.37 (+1.49%)
At close: October 30 at 3:04:54 PM GMT+8
Chart Range Bar
Loading chart for 000999.SZ
  • Previous Close 24.91
  • Open 24.89
  • Bid 25.25 x --
  • Ask 25.28 x --
  • Day's Range 24.81 - 25.47
  • 52 Week Range 21.60 - 30.65
  • Volume 15,751,315
  • Avg. Volume 10,541,905
  • Market Cap (intraday) 42.071B
  • Beta (5Y Monthly) -0.02
  • PE Ratio (TTM) 13.03
  • EPS (TTM) 1.94
  • Earnings Date --
  • Forward Dividend & Yield 1.01 (3.98%)
  • Ex-Dividend Date Oct 16, 2026
  • 1y Target Est 33.12

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese medicine health products; and vitamins, minerals, protein powder, collagen, probiotics, health foods, and formula granules. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. was incorporated in 1999 and is headquartered in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources Pharmaceutical Group Limited.

www.999.com.cn

30,304

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000999.SZ
7.47%
SSE Composite Index (000001.SS)
9.32%

1-Year Return

000999.SZ
8.05%
SSE Composite Index (000001.SS)
9.73%

3-Year Return

000999.SZ
8.25%
SSE Composite Index (000001.SS)
19.11%

5-Year Return

000999.SZ
107.08%
SSE Composite Index (000001.SS)
1.46%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 6.4B
Earnings 486.87M
Profit Margin 7.61%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
2B
4B
6B
8B
8.0%
9.0%
10.0%
11.0%
12.0%
13.0%

Analyst Insights

View More

Analyst Price Targets

21.50
33.12 Average
25.28 Current
53.13 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.40%

  • Return on Assets (ttm)

    4.93%

  • Return on Equity (ttm)

    10.16%

  • Revenue (ttm)

    31.03B

  • Net Income Avi to Common (ttm)

    3.23B

  • Diluted EPS (ttm)

    1.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.49B

  • Total Debt/Equity (mrq)

    10.30%

  • Levered Free Cash Flow (ttm)

    1.84B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: